Mechanisms of estrogen action in the cardiovascular system

Journal of Steroid Biochemistry and Molecular Biology

Volumn 74, Issue 5, 2000, Pages 337-343

  Mendelsohn, Michael E ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; NITRIC OXIDE SYNTHASE; PROSTACYCLIN SYNTHASE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STEROID HORMONE;

ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CELL PROLIFERATION; CONFERENCE PAPER; DRUG MECHANISM; ESTROGEN ACTIVITY; ESTROGEN THERAPY; GENE EXPRESSION; HEART MUSCLE; HEART PROTECTION; HUMAN; KNOCKOUT MOUSE; NONHUMAN; POSTMENOPAUSE OSTEOPOROSIS; VASCULAR ENDOTHELIUM;

ANIMALS; CARDIOVASCULAR SYSTEM; ENDOTHELIUM, VASCULAR; ESTROGENS; GENE DELETION; HUMANS; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; RECEPTORS, ESTROGEN; TIME FACTORS;

EID: 0034735852     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(00)00110-2     Document Type: Conference Paper

References (75)

1. Mechanisms of disease: The protective effects of estrogen on the cardiovascular system
2. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture
3. Postmenopausal estrogen therapy and cardiovascular disease
4. Hormonal treatment of postmenopausal women
5. Hormone therapy to prevent disease and prolong life in postmenopausal women
6. Estrogen and the blood vessel wall
7. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the lipid research clinics program follow-up study
8. Postmenopausal use of estrogen and occlusion of coronary arteries
9. The vascular protective effects of estrogen
10. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action
11. Human vascular smooth muscle cells contain functional estrogen receptor
12. Vascular smooth muscle cells as target for estrogen
13. Differential-display polymerase chain reaction identifies nucleophosmin as an estrogen-regulated gene in human vascular smooth muscle cells
14. Identification of authentic estrogen receptor in cultured endothelial cells: A potential mechanism for steroid hormone regulation of endothelial function
15. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells
16. Effects of 17β-estradiol on cytokine-induced endothelial cell adhesion molecular expression
17. Human vascular smooth muscle cells express an estrogen receptor isoform
18. Identification of a novel isoform of estrogen receptor, a potential inhibitor of estrogen action, in vascular smooth muscle cells
19. Dopaminergic and ligand-dependent activation of steroid hormone receptors
20. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
21. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
22. Growth factor activation of the estrogen receptor in vascular cells occurs via a MAP kinase-independent pathway
23. Coronary artery and cultured aortic smooth muscle cells express mRNA for both the classical estrogen receptor and the newly described estrogen receptor β
24. Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice
25. Increased expression of estrogen receptor β mRNA in male blood vessels following vascular injury
26. Selective estrogen receptor modulators: An alternative to hormone replacement therapy
27. Phytoestrogens - A short review
28. Aromatase expression in health and disease
29. Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture
30. The L-arginine-nitric oxide pathway
31. Non-genomic mechanism of 17β-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle
32. 2+ uptake
33. Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism
34. + channels
35. Estrogen relaxation of coronary artery smooth muscle is mediated by nitric oxide and cGMP
36. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium
37. 2+ mobilization
38. Specific, nongenomic actions of steroid hormones
39. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding
40. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen
41. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries
42. Mechanisms of estrogen-induced vasodilation: In vivo studies in canine coronary conductance and resistance arteries
43. Physiological concentrations of estradiol attenuate endothelin 1-induced coronary vasoconstriction in vivo
44. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women
45. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women
46. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women
47. Acute vascular effects of estrogen in postmenopausal women
48. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women
49. Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men
50. Conjugated estrogens acutely abolish abnormal cold-induced coronary vasoconstriction in male cardiac allografts
51. Stimulation of prostaglandin cyclooxygenase and prostacyclin synthetase activities by estradiol in rat aortic smooth muscle cells
52. Induction of calcium-dependent nitric oxide synthases by sex hormones
53. 17β-estradiol reduces vasoconstriction in endothelium-denuded rat aortas through inducible NOS
54. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta - Gender difference and effect of estrogen receptor gene disruption
55. Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene
56. Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man
57. Estradiol attenuates directed migration of vascular smooth muscle cells in vitro
58. Estrogen reduces proliferation and agonist-induced calcium increase in coronary artery smooth muscle cells
59. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model
60. Estradiol accelerates functional endothelial recovery after arterial injury
61. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP
62. Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis - Estradiol as a survival factor
63. Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery
64. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice
65. Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: Effects on migration and proliferation of vascular smooth muscle cells
66. Estrogen restores endothelial cell function in an experimental model of vascular injury
67. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery
68. Estrogen inhibits the response-to-injury in a mouse carotid artery model
69. Inhibition of the protective effect of estrogen by progesterone in experimental atherosclerosis
70. Different effects of estrogen and progesterone on experimental atherosclerosis in female versus male rabbits - Quantification of cellular proliferation by bromodeoxyuridine
71. Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment
72. Effects of estrogen on arterial wall structure and function
73. Generation and reproductive phenotype of mice lacking estrogen receptor beta
74. Estrogen inhibits the vascular injury in estrogen receptor-deficient female mice